Michiaki Fukui Selected Research

gluconolactonase

1/2015	Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes.
3/2012	Pancreatic insulin release in vitamin C-deficient senescence marker protein-30/gluconolactonase knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michiaki Fukui Research Topics

Disease

101	Type 2 Diabetes Mellitus (MODY) 03/2022 - 04/2003
23	Hypertension (High Blood Pressure) 05/2021 - 12/2006
22	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2003
18	Insulin Resistance 08/2021 - 01/2006
17	Hyperglycemia 05/2021 - 01/2004
16	Atherosclerosis 01/2022 - 01/2006
14	Diabetes Mellitus 03/2022 - 03/2012
14	Diabetic Nephropathies (Diabetic Nephropathy) 05/2020 - 01/2006
13	Fatty Liver 08/2021 - 01/2011
13	Non-alcoholic Fatty Liver Disease 05/2021 - 04/2010
11	Albuminuria 01/2016 - 09/2007
10	Obesity 03/2022 - 04/2015
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2021 - 03/2010
9	Body Weight (Weight, Body) 01/2022 - 10/2005
9	Hypertriglyceridemia 05/2021 - 11/2015
8	Dyslipidemias (Dyslipidemia) 05/2021 - 03/2012
6	Sarcopenia 01/2022 - 05/2018
6	Glucose Intolerance 05/2021 - 03/2008
6	Inflammation (Inflammations) 05/2021 - 03/2010
5	Neoplasms (Cancer) 01/2021 - 05/2005
5	Diabetes Complications 01/2020 - 07/2008
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 02/2003
4	COVID-19 01/2022 - 01/2021
4	Muscular Atrophy (Muscle Atrophy) 01/2022 - 07/2019
4	Chronic Renal Insufficiency 07/2019 - 06/2014
4	Abdominal Obesity 11/2017 - 11/2015
3	Stomach Neoplasms (Stomach Cancer) 06/2022 - 12/2009
3	Diabetic Retinopathy (Retinopathy, Diabetic) 04/2021 - 09/2007
3	Diabetic Angiopathies (Diabetic Angiopathy) 04/2021 - 04/2003
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 01/2020
3	Infections 03/2020 - 12/2008
3	Carotid Artery Diseases 02/2008 - 06/2003
2	Osteoporosis 03/2022 - 09/2007
2	Diarrhea 03/2022 - 11/2020
2	Constipation 03/2022 - 11/2020
2	Endometriosis 01/2022 - 12/2007
2	Atrophy 01/2022 - 01/2013
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2020
2	Dysbiosis 01/2021 - 11/2020
2	Anemia 12/2020 - 01/2015
2	Autoimmune Diseases (Autoimmune Disease) 04/2020 - 02/2007

Drug/Important Bio-Agent (IBA)

36	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 01/2004
27	AlbuminsIBA 07/2021 - 12/2004
25	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2008
22	CreatinineIBA 01/2022 - 08/2012
17	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2011
16	LipidsIBA 12/2019 - 06/2003
15	HDL CholesterolIBA 01/2022 - 04/2015
13	Insulin (Novolin)FDA Link 05/2021 - 07/2005
12	Testosterone (Sustanon)FDA Link 01/2020 - 06/2003
11	Indicators and Reagents (Reagents)IBA 05/2021 - 07/2008
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
9	Uric Acid (Urate)IBA 12/2018 - 05/2008
8	Blood Glucose (Blood Sugar)IBA 06/2022 - 03/2010
8	Biomarkers (Surrogate Marker)IBA 11/2020 - 12/2006
7	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 11/2010
7	AndrogensIBA 01/2021 - 02/2007
6	Metformin (Glucophage)FDA LinkGeneric 03/2022 - 01/2010
6	BilirubinIBA 05/2021 - 11/2008
6	CholesterolIBA 12/2019 - 01/2011
5	SaltsIBA 08/2021 - 12/2012
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2021 - 03/2008
5	CarbohydratesIBA 01/2018 - 01/2011
5	C-Reactive ProteinIBA 05/2013 - 12/2008
5	Dehydroepiandrosterone (DHEA)IBA 07/2008 - 12/2004
5	Dehydroepiandrosterone SulfateIBA 09/2007 - 12/2004
4	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 05/2021 - 06/2014
4	nasIBA 01/2020 - 04/2010
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 05/2005
4	Alanine Transaminase (SGPT)IBA 03/2019 - 06/2014
4	Pharmaceutical PreparationsIBA 01/2018 - 01/2011
4	AcidsIBA 07/2017 - 10/2007
4	Lipoproteins (Lipoprotein)IBA 01/2013 - 04/2008
4	Hemoglobin AIBA 12/2012 - 09/2007
3	Cystatin CIBA 01/2022 - 05/2018
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 10/2016
3	Serum AlbuminIBA 10/2021 - 03/2010
3	Ethanol (Ethyl Alcohol)IBA 08/2021 - 12/2018
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2020
3	Antihypertensive Agents (Antihypertensives)IBA 11/2019 - 12/2012
3	LDL CholesterolIBA 07/2019 - 01/2011
3	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2019 - 03/2013
3	Dietary ProteinsIBA 01/2019 - 07/2015
3	glimepiride (Amarel)FDA LinkGeneric 01/2014 - 10/2005
3	Pepsinogen A (Pepsinogen)IBA 01/2013 - 04/2012
3	oxidized low density lipoproteinIBA 01/2013 - 01/2010
2	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2022 - 07/2019
2	EnzymesIBA 01/2022 - 04/2003
2	HDL LipoproteinsIBA 08/2021 - 01/2016
2	VitaminsIBA 07/2021 - 03/2013
2	Acarbose FDA LinkGeneric 06/2021 - 04/2008
2	Ointments (Pastes)IBA 04/2021 - 12/2020
2	SodiumIBA 01/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	PalmitatesIBA 01/2021 - 11/2010
2	Estrogens (Estrogen)FDA Link 01/2020 - 02/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2020 - 02/2008

Therapy/Procedure

21	Glycemic Control 01/2022 - 12/2004
7	Therapeutics 05/2021 - 10/2005
2	Gastrectomy 06/2022 - 01/2020